FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059547002> ?p ?o ?g. }

• W2059547002 endingPage "245" @default.
• W2059547002 startingPage "241" @default.
• W2059547002 abstract "La hipertensión arterial (HTA) resistente requiere un abordaje global del riesgo cardiovascular. El objetivo del presente estudio ha sido analizar la agregación de factores de riesgo cardiovascular y la prevalencia de síndrome metabólico (SM) en una serie de sujetos con HTA resistente. Se incluyó de forma secuencial a 115 personas con HTA resistente, definida como un valor de presión arterial (PA) en consulta de 140/90 mmHg o mayor en tratamiento con 3 fármacos, uno de ellos diurético, durante un mínimo de 2 meses en buenos cumplidores. Se aplicó el protocolo de la Unidad de HTA: seguimiento de la PA de 24 h con un monitor Spacelabs 90202 o 90207, y ecocardiografía Doppler en modo M de buena calidad en 68 sujetos. Se consideró HTA seudorresistente cuando los valores de PA media diurna eran menores de 135/85 mmHg. La edad media (desviación estándar) fue de 61 (10) años y 50 pacientes (44%) eran varones. El valor medio de la PA en consulta fue de 166/95 (16/9) mmHg, y el de la PA diurna de 141/83 (15/12) mmHg. Tenían antecedentes familiares de enfermedad cardiovascular 88 sujetos (76,5%), de obesidad 64 (56%), de hipercolesterolemia 43 (37%), de concentración baja de colesterol unido a lipoproteínas de alta densidad 34 (30%), de sedentarismo 63 (55%) y de diabetes mellitus 32 (28%). La prevalencia de SM fue del 54%. Presentaban hipertrofia ventricular izquierda 49 pacientes (72%), lesiones de órgano diana 70 (61%) y un trastorno clínico asociado 44 (38%). En 31 casos (27%) se observó HTA seudorresistente; no se encontraron diferencias significativas en las distintas variables con los resistentes verdaderos. Los pacientes con HTA resistente en la consulta, independientemente de que tengan la PA ambulatoria controlada, presentan un riesgo muy elevado de experimentar un episodio cardiovascular, dada la importante agregación de factores de riesgo cardiovascular y la alta prevalencia de SM. El manejo de estos hipertensos requiere la optimización del tratamiento antihipertensivo, así como medidas o programas específicos del tratamiento de la obesidad y del sedentarismo. The aim of this study was to analyse the clustering of cardiovascular risk factors and the prevalence of metabolic syndrome (MS) in this sample of subjects with resistant hypertension (RH). One hundred and fifteen subjects with RH were sequentially included. RH was defined as a level of office blood pressure (BP) ≥ 140/90 mmHg in subjects treated with at least 3 antihypertensive drugs (one of them a diuretic) during at least 2 months and with good compliance. The usual protocol of the Hypertension Unit and ambulatory BP monitoring during 24 h was applied on all the subjects, and an echocardiogram with Doppler was performed on 68 of them. Subjects with a daytime BP < 135/85 mmHg were defined as pseudoresistant hypertensive. The mean age (standard deviation) was 61 (10) years, and 50 patients (44%) were males. The mean office BP was 166/95 (16/9) mmHg. The daytime BP was 141/83 (15/12) mmHg. Out of the patients, 88 (76.5%) had a family history of cardiovascular disease; 64 (56%) of obesity; 43 (37%) of hypercholesterolemia; 34 (30%) of low high-density lipoprotein cholesterol; 32 (28%) of diabetes mellitus; and 63 (55%) were sedentary. The prevalence of MS was 54%; target organ damage was found in 70 cases (61%), and 44 (38%) had other associated clinical conditions. Out of the subjects with echocardiography, 49 (72%) presented left ventricular hypertrophy. Pseudoresistant hypertension was found in 31 (27%). There were no significant differences in clinical variables between subjects with RH or psudoresistant hypertension. Patients with RH had high cardiovascular risk, independent of a good control of ambulatory BP, because of the high prevalence of cardiovascular risk factors and MS. An optimal antihypertensive treatment including specific programs for the control of obesity and a sedentary lifestyle are necessary in the management of these patients." @default.
• W2059547002 created "2016-06-24" @default.
• W2059547002 creator A5011615587 @default.
• W2059547002 creator A5043244862 @default.
• W2059547002 creator A5076804115 @default.
• W2059547002 creator A5088625361 @default.
• W2059547002 date "2006-07-01" @default.
• W2059547002 modified "2023-09-30" @default.
• W2059547002 title "Agregación de factores de riesgo cardiovascular y de prevalencia de síndrome metabólico en personas con hipertensión arterial resistente" @default.
• W2059547002 cites W1710832400 @default.
• W2059547002 cites W1966752541 @default.
• W2059547002 cites W1969976564 @default.
• W2059547002 cites W1992609447 @default.
• W2059547002 cites W1992890029 @default.
• W2059547002 cites W2001657480 @default.
• W2059547002 cites W2002868671 @default.
• W2059547002 cites W2008386859 @default.
• W2059547002 cites W2008736090 @default.
• W2059547002 cites W2014101805 @default.
• W2059547002 cites W2014601540 @default.
• W2059547002 cites W2020581345 @default.
• W2059547002 cites W2042873619 @default.
• W2059547002 cites W2047812211 @default.
• W2059547002 cites W2058153849 @default.
• W2059547002 cites W2060449981 @default.
• W2059547002 cites W2066349496 @default.
• W2059547002 cites W2068236391 @default.
• W2059547002 cites W2092430951 @default.
• W2059547002 cites W2094325634 @default.
• W2059547002 cites W2097281653 @default.
• W2059547002 cites W2107599980 @default.
• W2059547002 cites W2112583737 @default.
• W2059547002 cites W2115879629 @default.
• W2059547002 cites W2118310760 @default.
• W2059547002 cites W2119963086 @default.
• W2059547002 cites W2123289485 @default.
• W2059547002 cites W2137911781 @default.
• W2059547002 cites W2138338054 @default.
• W2059547002 cites W2156121263 @default.
• W2059547002 cites W2159793865 @default.
• W2059547002 cites W2163456626 @default.
• W2059547002 cites W2170262491 @default.
• W2059547002 cites W2323645720 @default.
• W2059547002 cites W2414167269 @default.
• W2059547002 cites W242641253 @default.
• W2059547002 cites W2912937774 @default.
• W2059547002 cites W3080346889 @default.
• W2059547002 doi "https://doi.org/10.1157/13091263" @default.
• W2059547002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16942725" @default.
• W2059547002 hasPublicationYear "2006" @default.
• W2059547002 type Work @default.
• W2059547002 sameAs 2059547002 @default.
• W2059547002 citedByCount "18" @default.
• W2059547002 countsByYear W20595470022014 @default.
• W2059547002 countsByYear W20595470022015 @default.
• W2059547002 countsByYear W20595470022016 @default.
• W2059547002 crossrefType "journal-article" @default.
• W2059547002 hasAuthorship W2059547002A5011615587 @default.
• W2059547002 hasAuthorship W2059547002A5043244862 @default.
• W2059547002 hasAuthorship W2059547002A5076804115 @default.
• W2059547002 hasAuthorship W2059547002A5088625361 @default.
• W2059547002 hasConcept C138885662 @default.
• W2059547002 hasConcept C15708023 @default.
• W2059547002 hasConcept C29456083 @default.
• W2059547002 hasConcept C71924100 @default.
• W2059547002 hasConceptScore W2059547002C138885662 @default.
• W2059547002 hasConceptScore W2059547002C15708023 @default.
• W2059547002 hasConceptScore W2059547002C29456083 @default.
• W2059547002 hasConceptScore W2059547002C71924100 @default.
• W2059547002 hasIssue "7" @default.
• W2059547002 hasLocation W20595470021 @default.
• W2059547002 hasLocation W20595470022 @default.
• W2059547002 hasOpenAccess W2059547002 @default.
• W2059547002 hasPrimaryLocation W20595470021 @default.
• W2059547002 hasRelatedWork W1489783725 @default.
• W2059547002 hasRelatedWork W1506200166 @default.
• W2059547002 hasRelatedWork W2039318446 @default.
• W2059547002 hasRelatedWork W2080531066 @default.
• W2059547002 hasRelatedWork W2373994074 @default.
• W2059547002 hasRelatedWork W2748952813 @default.
• W2059547002 hasRelatedWork W2780146991 @default.
• W2059547002 hasRelatedWork W2896609434 @default.
• W2059547002 hasRelatedWork W2899084033 @default.
• W2059547002 hasRelatedWork W3012411836 @default.
• W2059547002 hasVolume "127" @default.
• W2059547002 isParatext "false" @default.
• W2059547002 isRetracted "false" @default.
• W2059547002 magId "2059547002" @default.
• W2059547002 workType "article" @default.